| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |